AP203
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AP203, covering 2025-03-26 to 2025-03-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies [Phase 1, Phase 2]